The development of Tirzepatide , the powerful dual-action GLP-1 and GIP agonist, is revolutionizing how we treat obesity. Known by the brand name Mounjaro , this medication offers patients unprecedented results. As Mounjaro becomes officially available, many patients are weighing a critical choice: the brand name versus the compounded option. This choice revolves around compounded Tirzepatide cost  and availability, impacting your budget, convenience, and safety profile. Th